Inovio Investors Move For Cert. In COVID-19 Vaccine Suit
A class of investors moved for certification Thursday in their suit against biotechnology firm Inovio Pharmaceuticals Inc. and a cohort of company executives alleging that they misled the public about a...To view the full article, register now.
Already a subscriber? Click here to view full article